| 0 | 💬 0 |
A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-03-17 | #vaccination #clinical trial #immunogenicity #safety |